{
    "title": "Biogen lifts full-year profit forecast as Tecfidera boosts quarter",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8548703/Biogen-lifts-year-profit-forecast-Tecfidera-boosts-quarter.html",
    "date": "2020-07-22",
    "keywords": [
        "tecfidera",
        "forecast",
        "companys",
        "drug",
        "biogen",
        "trisha",
        "profit",
        "aducanumab",
        "quarter",
        "officer",
        "share",
        "priority",
        "review",
        "wednesday",
        "sclerosis",
        "treatment",
        "drugmaker",
        "mood",
        "setback",
        "june",
        "patent",
        "uncertainty",
        "approval",
        "competition",
        "growth",
        "year",
        "market",
        "property",
        "loss",
        "delay",
        "beatandraise",
        "analyst",
        "marc",
        "goodman",
        "tuesday",
        "fullyear",
        "impact",
        "entry",
        "company",
        "food",
        "administration",
        "marketing",
        "application",
        "voucher",
        "spinraza",
        "sandrock",
        "conference",
        "call",
        "street",
        "position",
        "seller",
        "refinitiv",
        "ibes",
        "revenue",
        "reporting",
        "roy",
        "manas",
        "mishra",
        "bengaluru",
        "editing",
        "bernard",
        "orr",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}